Poseida Therapeutics Ownership | Who Owns Poseida Therapeutics?

Overview Forecast RevenueFinancials Chart

Poseida Therapeutics Ownership Summary

Poseida Therapeutics is owned by 31.47% institutional investors, 27.64% insiders, and 40.89% retail investors. Fmr is the largest institutional shareholder, holding 10.30% of PSTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.65% of its assets in Poseida Therapeutics shares.

PSTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Poseida Therapeutics	31.47%	27.64%	40.89%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	10.01M	10.30%	$96.11M
Pentwater capital management lp	8.63M	8.88%	$82.80M
Blackrock funding, inc. /de	5.63M	5.80%	$54.06M
Nomura	5.12M	5.26%	$49.10M
Blackrock	4.91M	5.11%	$14.32M
Boxer capital	4.47M	4.66%	$13.07M
Vanguard group	3.83M	3.95%	$36.81M
Alpine associates management	2.02M	2.08%	$19.36M
Geode capital management	1.63M	1.68%	$15.65M
State street	1.59M	1.64%	$15.31M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aisling capital management lp	1.04M	3.55%	$10.02M
Silverarc capital management	1.01M	2.13%	$9.72M
Fifth lane capital, lp	50.10K	1.41%	$480.96K
Alpine associates management	2.02M	1.17%	$19.36M
Pentwater capital management lp	8.63M	0.91%	$82.80M
Boxer capital	4.47M	0.69%	$13.07M
Yakira capital management	177.40K	0.62%	$1.70M
Trium capital llp	386.41K	0.53%	$3.71M
Tig advisors	685.60K	0.46%	$6.58M
Harvest management	80.00K	0.37%	$768.00K

Top Buyers

Holder	Shares	% Assets	Change
Nomura	5.12M	0.07%	5.12M
Pentwater capital management lp	8.63M	0.91%	2.65M
Alpine associates management	2.02M	1.17%	2.02M
Tig advisors	685.60K	0.46%	685.60K
Glazer capital	521.11K	0.34%	521.11K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	10.01M	0.01%	-4.56M
Silverarc capital management	1.01M	2.13%	-2.68M
Millennium management	136.12K	0.00%	-2.06M
Blair william & co/il	-	-	-1.11M
Octagon capital advisors lp	-	-	-736.00K

New Positions

Holder	Shares	% Assets	Change	Value
Nomura	5.12M	0.07%	5.12M	$49.10M
Alpine associates management	2.02M	1.17%	2.02M	$19.36M
Tig advisors	685.60K	0.46%	685.60K	$6.58M
Glazer capital	521.11K	0.34%	521.11K	$5.00M
Highbridge capital management	400.00K	0.14%	400.00K	$3.84M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-13.00
Allspring global investments	-34.00
Srs capital advisors	-38.00
Gamma investing	-42.00
Farther finance advisors	-80.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	68	-30.61%	30,574,325	-42.86%	31	1.04%	46	-13.21%	12	-42.86%
Sep 30, 2024	97	3.19%	53,501,171	1.05%	55	1.81%	53	-	21	-
Jun 30, 2024	94	1.08%	52,945,375	0.40%	55	1.61%	53	6.00%	21	-8.70%
Mar 31, 2024	93	3.33%	52,736,698	16.63%	58	2.42%	50	4.17%	23	-4.17%
Dec 31, 2023	90	2.27%	45,216,197	0.03%	49	1.81%	48	17.07%	24	9.09%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	4.54M	4.65%	49.24K
Fidelity Growth Compy Commingled Pl O	4.41M	4.54%	12.03K
Fidelity Growth Company Fund	3.41M	3.49%	-69.66K
Fidelity Select Health Care	2.39M	2.45%	-
Vanguard Total Stock Mkt Idx Inv	2.19M	2.24%	47.66K
iShares Russell 2000 ETF	1.82M	1.86%	-6.97K
Fidelity Advisor Health Care I	1.45M	1.49%	-
Fidelity Growth Company K6	1.21M	1.24%	-26.18K
Vanguard Institutional Extnd Mkt Idx Tr	1.09M	1.12%	96.97K
Fidelity Series Growth Company	858.56K	0.88%	-67.60K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 10, 2024	Gergen Mark J	Executive Chairman	Sell	$283.87K
Nov 26, 2024	Gergen Mark J	Executive Chairman	Sell	$278.10K
Aug 08, 2022	Malin Life Sciences Holdings Ltd		Buy	$7.53M
Aug 08, 2022	Ostertag Eric	Executive Chairman	Buy	$500.00K
Aug 03, 2022	Ostertag Eric	Executive Chairman	Sell	$592.81K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	2
2024 Q2	-	-
2024 Q1	-	-
2023 Q2	-	-

PSTX Ownership FAQ

Who Owns Poseida Therapeutics?

Poseida Therapeutics shareholders are primarily institutional investors at 31.47%, followed by 27.64% insiders and 40.89% retail investors. The average institutional ownership in Poseida Therapeutics's industry, Biotech Stocks , is 68.48%, which Poseida Therapeutics falls below.

Who owns the most shares of Poseida Therapeutics?

Poseida Therapeutics’s largest shareholders are Fmr (10.01M shares, 10.30%), Pentwater capital management lp (8.62M shares, 8.88%), and Blackrock funding, inc. /de (5.63M shares, 5.80%). Together, they hold 24.98% of Poseida Therapeutics’s total shares outstanding.

Does Blackrock own Poseida Therapeutics?

Yes, BlackRock owns 5.11% of Poseida Therapeutics, totaling 4.91M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.32M$. In the last quarter, BlackRock decreased its holdings by -44.91K shares, a -0.91% change.

Who is Poseida Therapeutics’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is Poseida Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.55% of its assets in 1.04M Poseida Therapeutics shares, valued at 10.02M$.

Who is the top mutual fund holder of Poseida Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Poseida Therapeutics shares, with 4.65% of its total shares outstanding invested in 4.54M Poseida Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools